MOSCOW, February 7 – RIA Novosti. Hungarian Minister of Social Resources Miklos Kashler said that the Hungarian National Health Center has finally approved the use of the Russian Sputnik V coronavirus vaccine.
“The National Center for Public Health has completed the necessary formal studies of the Sputnik V vaccine, which have determined that the vaccine meets the manufacturer's specifications in terms of product quality and is suitable for use in humans,” Kashler said on Facebook.
The minister added that, thus, four vaccines against coronavirus have been approved for use in Hungary: drugs from Pfizer / BioNTech, Moderna and AstraZeneca, as well as Sputnik V.
The scientific journal Lancet previously published the results of the third phase of clinical trials “Sputnik V”, confirming the high efficacy and safety of the vaccine. During phase III clinical trials, Sputnik V demonstrated high rates of efficacy, immunogenicity and safety – the vaccine efficacy was 91.6%. The vaccine provides complete protection against severe cases of the new coronavirus infection.
“Sputnik V” was registered by the Russian Ministry of Health in August 2020, it was developed by the Gamaleya Research Center for Electrochemistry. This vaccine was the first in the world to prevent COVID-19. Sputnik V is built on a well-studied and proven platform of human adenoviral vectors.
The use of the Sputnik V vaccine was previously approved in 21 countries: Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, the United Arab Emirates, Iran, the Republic of Guinea, Tunisia, Armenia, Mexico, Nicaragua and Republika Srpska (entity of Bosnia and Herzegovina), Lebanon and Myanmar.